Official Website of Pakistan Chest Society
Member Login PCS Journal
Menu ☰
  • About us
    • Vision & mission
  • Board of Directors
  • Registered Members (SECP)
  • Committees
    • Central Office Management Committee
    • Constitutional Committee
    • Guidelines Committee
      • Asthma Guidelines working group
      • COPD working Group
      • Pneumonia Guidelines working group
      • Guidelines Working Group for Pleural Diseases
      • TB Guidelines working group
      • Guidelines Working Group for Interventional Pulmonology
      • Guidelines Working Group for Sleep Medicine and Supportive Ventilation
      • ILD Guideline working group
      • Guidelines Working Group for Smoking Cessation
      • SLBP Guidelines working group
    • Scientific Committee
  • Publications
    • Journals
    • PCS Guidelines
  • Conferences
    • 2026
      • Scientific Program
      • Archives
        • Brochures
        • Photos
        • Videos
        • Misc
  • Other Academic Archives
  • Gallery
  • Contact Us

Asthma

Asthma Asthima Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is thought to be caused by a combination of genetic and environmental factors. Its diagnosis is usually based on the pattern of symptoms, response to therapy over time and spirometry. It is clinically classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic)[7] where atopy refers to a predisposition toward developing type 1 hypersensitivity reactions. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol) and oral corticosteroids. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or leukotriene antagonists may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. The occurrence of asthma has increased significantly since the 1970s. In 2011, 235–300 million people globally have been diagnosed with asthma, and it caused 250,000 deaths.  

Latest News

View More

Local & International Events

  • Local Events
  • International Events
No Slide Found In Slider.
COPD
Asthima
Critical Care
ILD